30% of listed firms on Saudi market are SMEs, says CMA chief
Saudi Gazette report
RIYADH — The chairman of the Capital Market Authority (CMA) Mohammed Al-Quwaiz highlighted the growing role of Saudi Arabia's financial market in supporting small and medium-sized enterprises (SMEs), citing significant efforts in recent years to expand listing opportunities and diversify financing tools.
Speaking during the Enterprise Support Council held as part of the 'Finance Week' organized by the General Authority for Small and Medium Enterprises (Monsha'at), Al-Quwaiz emphasized the impact of recent initiatives to empower entrepreneurs and business owners.
Al-Quwaiz stated that the Saudi market now provides nine financing channels for companies, most of which were developed in recent years. Among the most notable developments, he said, was the launch of the parallel market 'Nomu,' which has facilitated wider market access for SMEs.
Currently, 30 of the companies listed in the Saudi financial market are SMEs, 14 of which have graduated from the parallel market to the main market after achieving business growth. This, he noted, reflects the success of the investment climate cultivated by the CMA.
'The general market index for growth has increased tenfold since launch, and the market value has surged to approximately SR60 billion — a 26-fold increase. Liquidity in the parallel market has grown eightfold, with trading values in 2024 reaching SR14 billion,' said Al-Quwaiz.
He added that the CMA has updated listing and offering requirements to align with international best practices. New tools, such as direct listings, have been introduced, while regulatory barriers have been reduced in collaboration with other government entities to ease the listing process for SMEs.
The CMA has also worked with partner institutions to implement over 14 incentives supporting listing and offering, including advantages related to government procurement, credit rating, and company evaluation.
Al-Quwaiz also noted the growing role of financial technology in the market, with sector revenues rising by 105% year-on-year in 2024.
He underscored the importance of credit rating and evaluation in enabling companies to secure financing, particularly through debt instruments, calling them vital components for long-term growth and market sustainability.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Arab News
2 hours ago
- Arab News
Closing Bell: Saudi Arabia's main index declines to close at 10,840
RIYADH: Saudi Arabia's Tadawul All Share Index closed lower on Thursday, falling 164.08 points, or 1.49 percent, to end the session at 10,840.94. Trading turnover on the main index reached SR5.34 billion ($1.42 billion), with only 14 stocks recording gains while 238 declined. The Kingdom's parallel market, Nomu, also saw a downturn, losing 425.57 points, or 1.56 percent, to close at 26,798.14. A total of 28 stocks advanced while 63 retreated. The MSCI Tadawul 30 Index slipped 13.42 points, or 0.95 percent, to finish at 1,392.04. SEDCO Capital REIT Fund emerged as the session's best performer, with its share price rising 0.88 percent to SR6.85. Fawaz Abdulaziz Alhokair Co. followed with a 0.71 percent gain to SR19.84, while Tihama Advertising and Public Relations Co. rose 0.67 percent to SR15.10. On the downside, Al-Omran Industrial Trading Co. recorded the steepest loss, falling 9.15 percent to SR26.30. AYYAN Investment Co. dropped 7.35 percent to SR12.60, and Al Taiseer Group Talco Industrial Co. declined 7.26 percent to SR40.85. On the announcements front, the Saudi National Bank announced plans to issue US dollar-denominated notes under its Euro Medium-Term Note Program. According to a Tadawul filing, the issuance will be conducted through a special purpose vehicle and will be offered to eligible investors in Saudi Arabia and globally. The bank has appointed Abu Dhabi Commercial Bank PJSC, DBS Bank Ltd., Emirates NBD Bank P.J.S.C., Goldman Sachs International, HSBC Bank plc, J.P. Morgan Securities plc, Mashreqbank psc, and Mizuho International plc as joint lead managers and book-runners. SNB Capital Co., SMBC Bank International plc, and Standard Chartered were also mandated. The proceeds from the offering will be used to enhance Tier 2 capital, support general corporate purposes, and advance SNB's strategic goals. Final terms of the issuance will be determined based on market conditions. SNB shares edged up 0.14 percent to close at SR34.70. Meanwhile, Yaqeen Capital Co. announced it has deposited proceeds from the sale of fractional shares following a recent capital increase. A total of 308 shares were sold, generating SR3,451.76, with an average price of SR11.23 per share. The proceeds have been distributed to eligible shareholders via their investment-linked accounts.
Leaders
5 hours ago
- Leaders
Saudi Arabia, Netherlands Sign Agreements in Environmental, Agricultural Fields
Saudi Arabia and the Kingdom of the Netherlands have signed multiple agreements and memoranda of understanding (MoUs) aimed at strengthening cooperation in the fields of environment, water, and agriculture. These agreements, involving both public and private sector entities from both countries, include investments totaling more than SAR 428 million. The funds will be directed toward developing and localizing advanced technologies in these critical sectors. The signings took place during the visit of Saudi Vice Minister of Environment, Water and Agriculture, Eng. Mansour bin Hilal Al Mushaiti, to the Netherlands from June 10 to 12. A total of 27 agreements and MoUs were formalized in the presence of senior ministry officials and representatives from Saudi and Dutch organizations. This visit aligns with the Ministry's broader strategy to elevate the global competitiveness of Saudi Arabia's agricultural sector, promote the production and export of local agricultural goods, enhance trade relations with the Netherlands, and deepen international cooperation. These efforts support the objectives of Saudi Vision 2030. Related Topics: Saudi Arabia, Netherlands Discuss Trade Cooperation ROSHN Green Initiative Center: Inspiring Future Environmental Leaders Saudi Arabia Welcomes Foreign Real Estate Investors Outside Holy Cities All You Need to Know about Hajj Rituals: A Step-by-Step Guide Short link : Post Views: 7 Related Stories
Saudi Gazette
10 hours ago
- Saudi Gazette
Charting a value-driven healthcare future: BD Saudi Arabia's GM on local impact, innovation, and Vision 2030
In a candid conversation with Saudi Gazette, Omar Malabarey, newly appointed Country General Manager for Becton Dickinson in Saudi Arabia, shares his vision for the company's role in the Kingdom's fast-evolving healthcare sector. With decades of experience across public and private healthcare, Malabarey discusses BD's commitment to local talent development, digital transformation, and strategic partnerships aligned with Vision 2030. Q: Congratulations on your appointment as General Manager of BD in Saudi Arabia. Can you share your journey leading to this role and what it means to you? A: My journey in healthcare has been both dynamic and fulfilling. I graduated in Radiological Sciences from the University of Wales (UK)and began my career as a radiology technologist at a Military hospital in Riyadh, Saudi Arabia. Following a decade in public healthcare, I transitioned to the corporate sector, where I held several senior leadership roles in digital health services. My journey then took me to the Ministry of Investment (formerly SAGIA), where I was the managing director for healthcare investment and promotion efforts responsible of medical devices , medical services , digital health and pharmaceutical investments . Before joining BD, I held the role of Chief commercial officer (CCO)at the National Unified Procurement Company) NUPCO. Stepping into this role at BD is a natural continuation of my mission to enhance the healthcare ecosystem system in KSA. BD has a legacy of innovation in medical technology, and I am honoured to lead its efforts in Saudi Arabia to drive impactful healthcare transformation. A: My priorities span both internal and external objectives. Internally, I am focused on fostering a strong, collaborative workplace culture. A key priority is to establish BD as an employer of choice in Saudi Arabia, attracting and retaining top local talent while ensuring alignment with the Kingdom's Saudization my goal is to strengthen BD's presence and visibility in the Saudi market. While BD products are widely recognized, our corporate brand needs greater prominence among healthcare stakeholders. I want to position BD as not just a provider of high-quality medical technology but also as a key partner in Saudi Arabia's Vision 2030 and the Health Sector Transformation Program. Our focus is on value-driven healthcare—delivering not just products but comprehensive solutions, education, and best practices that enhance patient outcomes.A strong part of my role will be pursue rolling out our Signature Programmes™ in Saudi Arabia, which focus on three critical areas: Patient Safety, Healthcare Worker Safety, and Healthcare Efficiency. These initiatives are designed to enhance infection control, improve hospital workflows, and to help ensure the safety of both patients and medical professionals. Through these programmes, BD is helping hospitals and healthcare institutions in Saudi Arabia implement best practices that drive meaningful improvements in patient outcomes and operational efficiencies.A: Saudi Arabia is undergoing a rapid and ambitious healthcare transformation under the leadership of the custodian of the two holy mosques King Salman and HRH the Crown Prince Mohammed bin Salman. Vision 2030's Health Sector Transformation Program aims to create a world-class healthcare system that is efficient, patient-centric, and digitally is fully aligned with this vision. We are not just a medical technology provider but a healthcare solutions partner, committed to driving innovation, education, and collaboration. Our focus is on automation, digital health solutions, and value-based procurement, all of which contribute to making healthcare more efficient and Arabia's commitment to digitalization is unmatched. It is the leading nation in digitization, and we see this reflected in healthcare. BD is supporting this shift by introducing smart medication management systems and robotics to enhance pharmacy automation, reduce human error, and improve patient care.A: Certainly. BD has evolved from a scientific office to a full commercial entity in Saudi Arabia, employing approximately 170 professionals and working alongside seven strategic distributors. Our commitment to Saudization is strong, and we continue to develop local talent in line with national workforce of our most exciting developments is the BD Training Center in Riyadh, which officially launched in April this year. This state-of-the-art facility will serve as a hub for healthcare professionals, providing hands-on training on BD's medical technologies, best practices, and clinical applications. It will also support technical training for engineers, ensuring seamless device maintenance and we also hosted our inaugural BD Healthcare Summit in Riyadh under the theme 'Embracing a Value Driven Future,' bringing together healthcare leaders to explore how AI, automation, and workforce empowerment can drive better outcomes in line with Saudi Arabia's Vision BD has established a Regional Headquarters (RHQ) in Saudi Arabia, reinforcing our commitment to regional operations and market the collaboration front, we have signed an MoU with STC to explore digital health solutions and are in discussions with multiplekey players to drive healthcare innovation. We also have an ongoing partnership with the Saudi Nursing Association, focusing on enhancing nursing education and clinical competency.A: Saudi Arabia is embracing cutting-edge healthcare solutions, and BD is at the forefront of this transformation. One of our key areas of focus is medication management systems and robotics, which optimize pharmacy automation, helping to ensure precise and efficient medication dispensing. These technologies not only enhance patient safety but also improve workflow efficiency in hospitals and are also expanding our digital health solutions, aligning with Saudi Arabia's drive for smart healthcare systems. Our goal is to integrate automation, data-driven healthcare, and AI-supported medical technologies that elevate patient care standards.A: Yes, partnerships are a key pillar of BD's strategy in Saudi Arabia. We have collaborated with Al Mujtamaa Pharmacy, making it the first digitally enabled pharmacy in Saudi Arabia using BD's advanced technology solutions. Additionally, BD has signed an MoU with STC, with further partnerships in discussion with Mobily and others toadvance digital healthcare and supply chain efficiency.A notable collaboration is our partnership with the Saudi Nursing Association, which focuses on continuous education and professional development for nurses across the Kingdom. This initiative underscores BD's commitment to capacity-building in the healthcare workforce.A: The Saudi healthcare sector is moving toward value-based healthcare and value-based procurement models, where hospitals and institutions prioritize quality outcomes over mere cost efficiency. BD is actively engaging in this transition, particularly in laboratory solutions and major trend is digital transformation, where automation and data analytics are playing a pivotal role in improving healthcare services. BD is driving innovation in pharmacy automation, digital medication management, and clinical diagnostics to support this we see a strong push toward local manufacturing and public-private partnerships, and BD is keen to explore opportunities that align with these national priorities.A: My vision is clear: BD is here to stay and to lead. We are not just another healthcare technology provider; we are a long-term partner in Saudi Arabia's healthcare role extends beyond revenue growth—we are committed to delivering value to patients, healthcare professionals, and the government. BD will continue to support innovation, drive medical education, and contribute to the national healthcare transformation through strategic partnerships and advanced solutions.A major part of this commitment is our focus on our Signature Programmes™, which align with the Kingdom's healthcare objectives. Through our investments, workforce development, and collaborations, BD is reinforcing its position as a trusted healthcare enabler in the Kingdom.A: I want to emphasize that BD's mission in Saudi Arabia is deeply rooted in improving patient care and healthcare efficiency. We are here not just to provide medical devices but to transform the healthcare experience, ensuring better outcomes for patients and healthcare professionals is at the heart of BD, and we will continue to introduce cutting-edge technologies and best practices that align with the Kingdom's Vision 2030. Our training center, our partnerships, and our digital health initiatives all reflect BD's dedication to making a meaningful impact in Saudi Arabia's healthcare landscape.
